NCT06781697: InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpression
- State
- Under way
- Phase
- Phase 3
- People
- 31 planned
- Started
- 3 May 2026
- Primary completion
- Dec 2027
- Arms
- VR-Ketamine (VR-K)
- Results
- None posted
- 17 Jan 2025: Trial registered
- 3 May 2026: Trial started